CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument
Abnormal Hemoglobin Quantitation. 510(k) K232027, from Sebia (Norcross, GA). Product code GKA, class 2.
As of Nov 20, 2026, K232027 is an FDA 510(k) held by Sebia, substantially equivalent on Apr 4, 2024 after 272 days, with no recalls tied to it in FDA's recall database.
- Review time: 272 days
- Recalls: 0
The CAPI 3 NEONAT Hb kit is intended as a qualitative screen for the detection of normal hemoglobins (F and A) and abnormal hemoglobins (S, C, E, D and Bart’s) in blood from human new-born collected on filter paper. This analysis is performed by capillary electrophoresis with the CAPILLARYS 3 DBS instrument.
- Capillarys Neonat HB (Pn 2006)K091283 · Sebia · Feb 22, 2010
- Premier Resolution SystemK222635 · Trinity Biotech (Primus Corporation, Dba Trinity Biotech) · Aug 4, 2023
- V8 Nexus Hemoglobin Ultrascreen, V8 AFSA2 Hemo ControlK192931 · Helena Laboratories, Corp. · Apr 19, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 7, 2023
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7415
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files